Healthcare is a highly regulated sector with economic and commercial pressures that mixed public and private sector funding can bring.
With our support, you can adapt to regulatory and market changes, safeguard patients and service users, and secure and grow your business.
Our knowledge of the sector is broad and deep and our multi-disciplinary team offers technical excellence across a comprehensive range of transactional, regulatory and advisory matters.
Our team works with healthcare operators, investors, business owners and the healthcare professionals that deliver these vital healthcare services.
We advise and partner with the leading operators and investors behind businesses providing social and specialist care, retirement living facilities, dental, veterinary and pharmacy services, nursery provision and medical products and clinical services.
Meet the team
Some of our clients
Charles Russell Speechlys advises Avicenna Group on duo of pharmacy group acquisitions
The acquisition takes Avicenna to a total of 135 pharmacy branches.
Pharmacy Brief - June 2021
The June edition of our Pharmacy Brief
Sam Milne writes for Pharmacy Business on the process of selling a pharmacy
Sam Milne outlines the process in making that all important decision to sell a pharmacy.
Helen Wong MBE
Dentistry - toothache ahead
Covid-19 and a public inquiry - what to expect
Noel Wardle quoted by Chemist and Druggist on how to make hub-and-spoke work for all independent pharmacies
Noel considers whether patients would be for or against their prescription being assembled at a hub, rather than a pharmacy.
Noel Wardle writes for Pharmacy Business on the balancing act of medicine supply
Do community pharmacies have to provide medicines in compliance aids, and can they charge for the service?
Property Patter: Navigating the complexities of Pharmacy Property
Pharmacy property is a specialist area which contains many traps for the unwary.
Charles Russell Speechlys promotes five to Partner
The promotions are effective 1 May 2021 and are accompanied by one Legal Director and 15 Senior Associate promotions.
Amelia Goodwin and Georgina O'Sullivan write for Pharmacy Business on managing employee performance
Why contractors should prioritise performance management of employees as a regular feature of their business strategy.
Sleep-in workers not entitled to NMW for entire shift
A unanimous ruling by The Supreme Court in the Royal Mencap v Tomlinson-Blake and another case.
Amelia Goodwin quoted by People Management, Home Care Insight and Care Home Management on the implications of the Supreme Court's ruling in Royal Mencap Society v Tomlinson-Blake
The court found that care providers do not have to pay the minimum wage to staff for time that they are asleep but on call during shifts.
Pharmacy Brief - March 2021
The March edition of our Pharmacy Brief
The firm's role in advising Dentex on the acquisition of The Essex Smile Centre reported by Business Money
The sale of The Essex Smile Centre to Dentex Healthcare Group Limited has been completed.
Natalie Deuchar and Leonora Owens write for Pharmacy Business on the considerations to take into account when pharmacists look to obtain a new unit
Pharmacists should be aware of the law when considering obtaining a new unit.
Noel Wardle quoted by Chemist and Druggist on the issues that need to be considered before pharmacies adopt a hub-and-spoke dispensing model
Under current legislation, the hub-and-spoke model can be carried out by pharmacies owned by the same legal entity.
Noel Wardle writes for Chemist and Druggist on whether pharmacy professionals can be sued for COVID vaccine negligence
Charles Russell Speechlys' Corporate team shortlisted for the 2021 South East Dealmakers Awards
Our Guildford team shortlisted at the Insider South East Dealmakers Awards 2021 for Corporate Law Firm of the Year.
Pharmacy Brief - December 2020
The December edition of our Pharmacy Brief
Charles Russell Speechlys advises Emergex Vaccines on $11m fundraising
Emergex is a UK-based biotechnology company and pioneers of developing synthetic ‘set point’ vaccines .